phenotype

AGING

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about AGING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

9776Connections

17Hypotheses

18Analyses

50Outgoing

50Incoming

0Experiments

20Debates

Summary

AGING is a phenotype associated with neurodegeneration research. Key relationships include: activates, associated with, regulates. Associated with AGE_RELATED_DISEASES, ALS, ALZHEIMER. Connected to 2696 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Epigenetic-Metabolic Coupling: SIRT1 Activator + NAD+ Precursor

idea · 3877 words

→

Pathway Diagram

graph TD
    subgraph Pathology["Pathology"]
        AGING["AGING"] -->|"associated with"| MICROGLIA["MICROGLIA"]
        AGING["AGING"] -->|"associated with"| Aging["Aging"]
        AGING["AGING"] -->|"associated with"| Alzheimer["Alzheimer"]
        AUTOPHAGY["AUTOPHAGY"] -->|"associated with"| AGING["AGING"]
        INFLAMMATION["INFLAMMATION"] -->|"associated with"| AGING["AGING"]
        ALZHEIMER_S_DISEASE["ALZHEIMER'S DISEASE"] -->|"causes"| AGING["AGING"]
        ALZHEIMER["ALZHEIMER"] -->|"causes"| AGING["AGING"]
    end
    subgraph Signaling["Signaling"]
        AGING["AGING"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        AGING["AGING"] -->|"activates"| Diabetes["Diabetes"]
        AGING["AGING"] -->|"activates"| Neuroinflammation["Neuroinflammation"]
        AGING["AGING"] -->|"activates"| Inflammation["Inflammation"]
        AGING["AGING"] -->|"activates"| Autophagy["Autophagy"]
        AGING["AGING"] -->|"regulates"| Aging_1["Aging"]
        AUTOPHAGY_2["AUTOPHAGY"] -->|"regulates"| AGING["AGING"]
        MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"activates"| AGING["AGING"]
    end
    style AGING fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEUROINFLAMMATION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Diabetes fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Aging fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Aging_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Alzheimer fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style AUTOPHAGY_2 fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style INFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIAL_DYSFUNCTION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER_S_DISEASE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style ALZHEIMER fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (4411)

Target	Relation	Type	Str
Inflammation	regulates	disease	1.00
Neurodegeneration	therapeutic_target	disease	1.00
Aging	regulates	disease	1.00
Als	regulates	disease	1.00
Aging	interacts_with	disease	1.00
Neuroinflammation	regulates	disease	1.00
Mtor	regulates	pathway	1.00
Autophagy	activates	pathway	1.00
Aging	inhibits	disease	1.00
Cancer	activates	disease	1.00
Cancer	regulates	disease	1.00
Mitochondrial Function	therapeutic_target	pathway	1.00
Neurodegeneration	regulates	disease	1.00
Neuroinflammation	activates	disease	1.00
Epigenetic	activates	pathway	1.00
Inflammasome	activates	pathway	1.00
Oxidative Stress	therapeutic_target	pathway	1.00
Nf-Κb	therapeutic_target	pathway	1.00
Autophagy	regulates	pathway	1.00
Alzheimer	therapeutic_target	disease	1.00
Mitophagy	activates	pathway	1.00
Als	therapeutic_target	disease	1.00
Aging	activates	disease	1.00
Inflammation	activates	disease	1.00
Epigenetic	regulates	pathway	1.00
Mitophagy	regulates	pathway	1.00
Alzheimer	activates	disease	1.00
Neurodegeneration	activates	disease	1.00
Immune Response	therapeutic_target	pathway	1.00
Diabetes	activates	disease	1.00
Immune Response	activates	pathway	1.00
Complement	activates	pathway	1.00
Immune Response	regulates	pathway	1.00
Autophagy	therapeutic_target	pathway	1.00
Apoptosis	therapeutic_target	pathway	1.00
neurodegeneration	associated_with	phenotype	1.00
Oxidative Stress	activates	pathway	1.00
Apoptosis	activates	pathway	1.00
Aging	therapeutic_target	disease	1.00
Mtor	therapeutic_target	pathway	1.00
Cardiovascular	therapeutic_target	disease	1.00
Autophagy	inhibits	pathway	1.00
Nf-Κb	activates	pathway	1.00
Autophagy	activates	pathway	1.00
Mtor	activates	pathway	1.00
Senescence	therapeutic_target	disease	1.00
NEUROINFLAMMATION	activates	gene	1.00
Oxidative Stress	inhibits	pathway	1.00
Blood-Brain Barrier	therapeutic_target	pathway	1.00
Parkinson	therapeutic_target	disease	1.00

Incoming (5365)

Source	Relation	Type	Str
NEURODEGENERATION	biomarker_for	gene	1.00
ALZHEIMER	causes	gene	1.00
ALS	therapeutic_target	gene	1.00
CYTOKINES	therapeutic_target	gene	1.00
NRF2	regulates	gene	1.00
ALZHEIMER'S DISEASE	causes	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
MICROGLIA	therapeutic_target	gene	1.00
TAU PATHOLOGY	associated_with	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
GAL	activates	gene	1.00
NF-ΚB	therapeutic_target	gene	1.00
CYTOKINES	activates	gene	1.00
MITOCHONDRIAL DYSFUNCTION	activates	gene	1.00
AGING	inhibits	gene	1.00
MITOPHAGY	therapeutic_target	gene	1.00
COMPLEMENT	activates	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
MITOPHAGY	regulates	gene	1.00
NEURODEGENERATIVE DISEASES	biomarker_for	gene	1.00
APOPTOSIS	activates	gene	1.00
CANCER	therapeutic_target	gene	1.00
PI3K	activates	gene	1.00
P53	activates	gene	1.00
AGING	activates	gene	1.00
GENES	therapeutic_target	gene	1.00
NRF2	therapeutic_target	gene	1.00
AMPK	therapeutic_target	gene	1.00
MITOCHONDRIAL DYSFUNCTION	therapeutic_target	gene	1.00
INFLAMMATION	regulates	gene	1.00
P53	therapeutic_target	gene	1.00
MTOR	regulates	gene	1.00
PARKIN	activates	gene	1.00
BAX	activates	gene	1.00
MTOR	therapeutic_target	gene	1.00
OVERVIEW	therapeutic_target	gene	1.00
GFAP	biomarker_for	gene	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
MICROGLIA	activates	gene	1.00
OXIDATIVE STRESS	therapeutic_target	gene	1.00
PI3K	therapeutic_target	gene	1.00
CANCER	activates	gene	1.00
DNA	regulates	gene	1.00
GENES	activates	gene	1.00
DNA	inhibits	gene	1.00
Stroke	associated_with	disease	1.00
AKT	activates	gene	1.00
AKT	therapeutic_target	gene	1.00
AMPK	activates	gene	1.00
ALZHEIMER'S DISEASE	causes	gene	1.00

Targeting Hypotheses (17)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Closed-loop tACS targeting entorhinal cortex layer II SST in	0.784	alzheimers	Circuit-level neural dynamics in neurode
TREM2-SIRT1 Metabolic Senescence Circuit in Microglial Aging	0.744	neurodegeneration	Gene expression changes in aging mouse b
Partial OSK Reprogramming Reverses Epigenetic Aging Without	0.630	neurodegeneration	Investigate mechanisms of epigenetic rep
PD genetic aging variants accelerating cell-type-specific ep	0.626	neurodegeneration	Genetic Aging Landscape Variants and Epi
SUV39H1 Restoration Represses Aberrant Transposon Expression	0.620	neurodegeneration	Investigate mechanisms of epigenetic rep

Cell-state stratification is required to resolve Genetic Agi	0.612	neurodegeneration	Genetic Aging Landscape Variants and Epi
Blocking Tau Packaging into Small Extracellular Vesicles via	0.610	neuroscience	Trans-synaptic tau spreading and propaga
Perturbation-first validation should precede therapeutic cla	0.608	neurodegeneration	Genetic Aging Landscape Variants and Epi
Neurovascular Permeability Score (NVPS): Composite Plasma +	0.600	-	Blood-brain barrier permeability changes
TNFRSF25-Mediated Aging Exosome Pathway Inhibition	0.587	neurodegeneration	Gene expression changes in aging mouse b
P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming	0.563	biomarkers	What biomarkers can reliably detect micr
Myelin Breakdown-Amyloid Interaction Amplifies Cortical Agin	0.512	alzheimer	Allen Mouse Brain Aging Atlas: cross-age
Targeted DNA Demethylation at the Klotho Locus via dCas9-TET	0.510	neurodegeneration	epigenetic reprogramming aging neurons
Composite Aging Risk Score (CARS) identifies hippocampus as	0.380	alzheimers	Gene expression changes in aging mouse b
AD Polygenic Risk Score predicts transcriptomic aging accele	0.280	-	Gene expression changes in aging mouse b
Multi-Cell Type Aging Clock Synchronization	0.000	-	Cell type vulnerability in Alzheimer's D
Inflammaging-Epigenome Decoupling Strategy	0.000	-	Epigenetic clocks and biological aging i

Mentioning Analyses (18)

Scientific analyses that reference this entity

What is the optimal dosage and timing of melatonin administration for AD prevent

neurodegeneration | 2026-04-26 | 7 hypotheses Top: 0.735

test debate

neurodegeneration | 2026-04-15 | 0 hypotheses

Are age-related static epigenetic patterns pathogenic or protective compensatory

epigenetics | 2026-04-15 | 0 hypotheses

What is the temporal sequence of TREM2 signaling transition from protective to i

neuroimmunology | 2026-04-15 | 1 hypotheses Top: 0.670

Does human glymphatic function show clinically relevant circadian variation like

neurodegeneration | 2026-04-12 | 0 hypotheses

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (4)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year
Death receptor 3: A paradoxical biomarker and therapeutic target in pan-cancer. [PMID:41605339]	Fang W, Du J, Xu Z, Liu Q, Liu Y et al.	Crit Rev Oncol Hematol	2026
Homocysteine as a biomarker in arthritis and depression: Evidence from NHANES an [PMID:41693749]	Deng C, He Z, Zhu X	SAGE Open Med	2026
The involvement of TNFRSF25 in age-related hearing loss. [PMID:41882185]	Roche MV, Tang PC, Yan D, De Marchena MR	Hum Genet	2026
Maternal immune activation perturbs intestinal niche through microbial glyceroph [PMID:41926285]	Chang H, Zhu X, Shen C, Xu X, Ni Y et al	Cell Rep	2026

Debates (20)

Multi-agent debates referencing this entity

Extended debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 6 · Score: 0.95 · 2026-04-27

Debate: Chromatin Remodeling-Mediated Nutrient Sensing Restoration

closed · Rounds: 4 · Score: 0.46 · 2026-04-27

Debate: TREM2 R47H Metabolic Lock-in at Cholesterol Ester Accumulation

closed · Rounds: 4 · Score: 0.59 · 2026-04-27

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.44 · 2026-04-27

Hypothesis debate: Nutrient-Sensing Epigenetic Circuit Reactivation

closed · Rounds: 4 · Score: 0.46 · 2026-04-27

What is the optimal dosage and timing of melatonin administration for AD prevent

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

closed · Rounds: 4 · Score: 0.50 · 2026-04-26

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

closed · Rounds: 4 · Score: 0.81 · 2026-04-23

Related Research

Hypotheses and analyses mentioning AGING in their description or question text

AGING

Understanding Entity Pages

Summary

Wiki Pages (1)

Epigenetic-Metabolic Coupling: SIRT1 Activator + NAD+ Precursor

Pathway Diagram

Outgoing (4411)

Incoming (5365)

Targeting Hypotheses (17)

Mentioning Analyses (18)

What is the optimal dosage and timing of melatonin administration for AD prevent

test debate

Are age-related static epigenetic patterns pathogenic or protective compensatory

What is the temporal sequence of TREM2 signaling transition from protective to i

Does human glymphatic function show clinically relevant circadian variation like

Do tau strains or regional cellular environments primarily drive PSP vs CBD path

What mechanisms drive TDP-43 pathology specifically in Alzheimer's disease versu

How does P2RY12-mediated VSMC dysfunction contribute to cerebrovascular neurodeg

Does SPP1-mediated synaptic engulfment represent beneficial clearance or patholo

Can chaperone enhancement approaches overcome tau seed saturation effects in adv

How do regional, age, and sex-dependent differences in microglial populations af

Epigenetic reprogramming in aging neurons

epigenetic reprogramming aging neurons

Neuroinflammation and microglial priming in early Alzheimer's Disease

Senescent cell clearance as neurodegeneration therapy

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

Experiments (0)

Related Papers (4)

Debates (20)

Extended debate: Metabolic Reprogramming to Reverse Senescence

Debate: Chromatin Remodeling-Mediated Nutrient Sensing Restoration

Debate: TREM2 R47H Metabolic Lock-in at Cholesterol Ester Accumulation

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: Nutrient-Sensing Epigenetic Circuit Reactivation

What is the optimal dosage and timing of melatonin administration for AD prevent

Hypothesis debate: SASP Modulation Rather Than Cell Elimination

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Hypothesis debate: Metabolic Reprogramming to Reverse Senescence

Should metabolic reprogramming via SIRT1/NAD+/PGC-1alpha axis be prioritized to

Related Research

Cell-state stratification is required to resolve Genetic Aging Landscape Variant

Blocking Tau Packaging into Small Extracellular Vesicles via ESCRT-III Pathway

Perturbation-first validation should precede therapeutic claims for Genetic Agin

Neurovascular Permeability Score (NVPS): Composite Plasma + Imaging Biomarker Pa

TNFRSF25-Mediated Aging Exosome Pathway Inhibition

P2X7R PET Imaging for NLRP3 Inflammasome-Associated Priming

Myelin Breakdown-Amyloid Interaction Amplifies Cortical Aging-Neurodegeneration

Targeted DNA Demethylation at the Klotho Locus via dCas9-TET1 Rescues Neuroprote

Composite Aging Risk Score (CARS) identifies hippocampus as the primary AD vulne

AD Polygenic Risk Score predicts transcriptomic aging acceleration in a dose-dep

Multi-Cell Type Aging Clock Synchronization

Inflammaging-Epigenome Decoupling Strategy